Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (96)
  3. Book Section (8)
  4. Review (8)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (256)
  2. Department of Medicine (256)
  3. Solid Tumor Oncology Division (256)
  4. Survivorship Research (256)
  5. Epidemiology and Biostatistics (102)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (17)
  6. Future Medicine (5)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: A feasibility study
    Journal Article

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
    Journal Article

    O’Shaughnessy, J.; Brufsky, A.; Rugo, H. S.; Tolaney, S. M.; Punie, K.; Sardesai, S.; Hamilton, E.; Loirat, D.; Traina, T.; Leon-Ferre, R.; more...
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Androgen receptor splice variant-7 in breast cancer: Clinical and pathologic correlations
    Journal Article

    Ferguson, D. C.; Mata, D. A.; Tay, T. KY.; Traina, T. A.; Gucalp, A.; Chandarlapaty, S.; D'Alfonso, T. M.; Brogi, E.; Mullaney, K.; Ladanyi, M.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Treatment exposure and discontinuation in the PALbociclib CoLlaborative Adjuvant Study of palbociclib with adjuvant endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
    Journal Article

    Mayer, E. L.; Fesl, C.; Hlauschek, D.; Garcia-Estevez, L.; Burstein, H. J.; Zdenkowski, N.; Wette, V.; Miller, K. D.; Balic, M.; Mayer, I. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Relationship between cognitive functioning and frailty in older breast cancer survivors
    Journal Article

    Ahles, T. A.; Schofield, E.; Li, Y.; Ryan, E.; Root, J. C.; Patel, S. K.; McNeal, K.; Gaynor, A.; Tan, H.; Katheria, V.; more...
    Journal of Geriatric Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
    Meeting Abstract

    Hegewisch-Becker, S.; Oliveira, M.; Traina, T.; Tolaney, S. M.; Loirat, D.; Punie, K.; Hurvitz, S. A.; Lynce, F.; Hamilton, E.; Nanda, R.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
    Meeting Abstract

    Kalinsky, K.; Oliveira, M.; Traina, T. A.; Tolaney, S. M.; Loirat, D.; Punie, K.; Hurvitz, S. A.; Lynce, F.; Hamilton, E. P.; Nanda, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save